98%
921
2 minutes
20
The personal, social and economic burden of chronic pain is enormous. Tremendous research efforts are being directed toward understanding, preventing, and managing chronic pain. Yet patients with chronic pain, clinicians and the public are sometimes poorly served by an evidence architecture that contains multiple structural weaknesses. These include incomplete research governance, a lack of diversity and inclusivity, inadequate stakeholder engagement, poor methodological rigour and incomplete reporting, a lack of data accessibility and transparency, and a failure to communicate findings with appropriate balance. These issues span pre-clinical research, clinical trials and systematic reviews and impact the development of clinical guidance and practice. Research misconduct and inauthentic data present a further critical risk. Combined, they increase uncertainty in this highly challenging area of study and practice, drive the provision of low value care, increase costs and impede the discovery of more effective solutions. In this focus article, we explore how we can increase trust in pain science, by examining critical challenges using contemporary examples, and describe a novel integrated conceptual framework for enhancing the trustworthiness of pain science. We end with a call for collective action to address this critical issue. PERSPECTIVE: Multiple challenges can adversely impact the trustworthiness of pain research and health research more broadly. We present ENTRUST-PE, a novel, integrated framework for more trustworthy pain research with recommendations for all stakeholders in the research ecosystem, and make a call to action to the pain research community.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jpain.2024.104736 | DOI Listing |
J Clin Epidemiol
August 2025
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Objectives: To explore the extent to which trustworthiness of treatment guidelines has changed since the introduction of Institute of Medicine (IOM) standards.
Study Design And Setting: In this systematic survey, we searched Medline, Embase, PsycINFO, and Trip from January to December 2010 (pre-IOM) and 2022 (post-IOM) for guidelines that were informed by a systematic review of evidence, written in English, and included recommendations for treatment of any health conditions in individuals of any age. Using the 10-item modified National Guideline Clearinghouse Extent of Adherence to Trustworthy Standards (NEATS) instrument, paired reviewers independently assessed trustworthiness of 70 randomly selected guidelines from 2010 and 70 from 2022.
Children (Basel)
July 2025
Department of Nursing, Umeå University, 901 87 Umeå, Sweden.
Parents of children with type 1 diabetes play a key role in managing their child's self-management, which can be stressful and burdensome. High involvement can lead to reactions such as emotional, cognitive, and physical exhaustion in parents. Understanding parents' psychosocial impact due to their child's disease is crucial for the family's overall well-being.
View Article and Find Full Text PDFJ Pain Symptom Manage
August 2025
Division of Palliative Medicine, Department of Family and Preventive Medicine, Emory University, Atlanta, GA, United States.
Background: AI holds increasing promise for enhancing palliative care through applications in prognostication, symptom management, and decision support. However, the utilization of real-world data, the rigor of validation, and the transparency and reproducibility of these AI tools remain largely unexamined, posing critical considerations for their safe and ethical integration in sensitive end-of-life settings.
Objectives: This scoping review systematically mapped the landscape of AI applications in palliative and hospice care, focusing on three key domains: (1) the purposes and data sources of AI models; (2) the methods and extent of model validation and generalizability; and (3) the degree of transparency and reproducibility.
Front Psychol
July 2025
Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zürich, Switzerland.
Background: For more than a decade, studies have supported the efficacy and safety of placebos without deception-so-called open-label placebos (OLPs)-to harness placebo effects in primary care while aligning with key ethical principles. Since treatment acceptance, feasibility, and successful implementation of novel interventions into clinical practice depend on patients' attitudes, patients' perspectives, perceived obstacles, and ideas on OLP use in clinical practice have yet to be elucidated. Therefore, patient and public involvement is increasingly demanded in research and its implementation into clinical practice.
View Article and Find Full Text PDFJ Multidiscip Healthc
August 2025
Rosemary Bryant AO Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
Purpose: Pain is a common, debilitating, and complex non-motor symptom of Parkinson's disease (PD), often requiring input from healthcare providers across various disciplines for effective management. The aims of this study were to explore the perspectives of people with PD on the provision of pain care services.
Methods: A qualitative descriptive research methodology employing a maximum variation sampling strategy was used to recruit people with PD, living in Australia.